BIOMAT Database Logo BIOMAT Database Logo

Autoimmune aspects of myasthenia gravis. 1985

R P Lisak, and A I Levinson, and B Zweiman

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000305 Adrenal Cortex Hormones HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE. Adrenal Cortex Hormone,Corticoid,Corticoids,Corticosteroid,Corticosteroids,Cortex Hormone, Adrenal,Hormone, Adrenal Cortex,Hormones, Adrenal Cortex
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D013934 Thymectomy Surgical removal of the thymus gland. (Dorland, 28th ed) Thymectomies

Related Publications

R P Lisak, and A I Levinson, and B Zweiman
Autoimmune aspects of myasthenia gravis.
January 1966, Proceedings of the Australian Association of Neurologists,
R P Lisak, and A I Levinson, and B Zweiman
[Autoimmune aspects of myasthenia gravis].
January 1970, Revista do Hospital das Clinicas,
R P Lisak, and A I Levinson, and B Zweiman
Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects.
January 1976, Annals of the New York Academy of Sciences,
R P Lisak, and A I Levinson, and B Zweiman
Molecular aspects of experimental autoimmune myasthenia gravis.
January 1981, Progress in clinical and biological research,
R P Lisak, and A I Levinson, and B Zweiman
Myasthenia gravis as an autoimmune disease: clinical aspects.
January 1966, Annals of the New York Academy of Sciences,
R P Lisak, and A I Levinson, and B Zweiman
Autoimmune myasthenia gravis.
January 1993, Hospital practice (Office ed.),
R P Lisak, and A I Levinson, and B Zweiman
Autoimmune myasthenia gravis.
March 2009, Expert review of neurotherapeutics,
R P Lisak, and A I Levinson, and B Zweiman
Autoimmune myasthenia gravis.
January 2013, Handbook of clinical neurology,
R P Lisak, and A I Levinson, and B Zweiman
Experimental autoimmune myasthenia gravis.
January 1988, Monographs in allergy,
R P Lisak, and A I Levinson, and B Zweiman
Experimental autoimmune myasthenia gravis.
July 1980, Journal of neurology, neurosurgery, and psychiatry,
Copied contents to your clipboard!